A portfolio of mouse monoclonal antibodies raised against Influenza PR-8 has been developed at the University of Cambridge. The antibodies target the HA or NA epitopes of the virus.

These antibodies have been described in:

J Virol. 2013, 87(8), 4694–4703.

J Gen Virol. 2009, 90(Pt 11), 2592–2603.

Download further information here.

Tags: